Clinical Trial Update: Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)

View source ↗

Summary

This completed clinical trial in Romania evaluated patient satisfaction in hepatitis C patients treated with PegIntron Pen and Rebetol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron Pen (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C | Status: COMPLETED | Results posted: 2009-06-02